Industry / Germany
VFA Criticises Shortage Of Innovative Drugs
January 2008 | Industry NewsGermany's Association of Research-based Pharmaceutical Companies (VFA) has warned that the country is lagging behind other European states when it comes to innovative pharmaceuticals. According to the VFA, only 6% of medicines in the country are under five years old, compared to 15% in France and the UK.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.
